V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038113 | 210008974 | 1.15 | 19.3 | Disease modification (D) | null | 2019-03-12 | Carboplatin AUC 2 - 5 | N | N | 210017129 | CARBOPLATIN |
| 210038114 | 210008994 | 1.74 | 93.5 | Curative (C) | 2015-02-01 | 2015-10-04 | Procarbazine | N | N | 210017201 | PROCARBAZINE |
| 210038115 | 210009038 | 0 | 74.7 | Curative (C) | 2017-06-03 | 2017-08-07 | IDELALISIB | 01 | N | 210017421 | NELARABINE |
| 210038116 | 210019717 | null | 67.2 | Curative (C) | 2017-04-19 | 2017-11-14 | Pentostatin | N | N | 210017422 | BEVACIZUMAB |
| 210038117 | 210009118 | 1.67 | 70.8 | Curative (C) | 2015-11-17 | 2015-11-22 | CHOP - 21 days | N | N | 210017673 | METHOTREXATE HIGH DOSE |
| 210038118 | 210009283 | null | 96 | Palliative (P) | null | 2017-07-19 | CHLORAMBUCIL + OFATUMUMAB | Y | N | 210018278 | UKALL XII |
| 210038119 | 210030811 | null | null | Curative (C) | 2018-11-11 | 2018-12-31 | Bendamustine +/- Prednisolone | N | N | 210018518 | CHLORAMBUCIL + OFATUMUMAB |
| 210038120 | 210009736 | 0 | 72 | Curative (C) | 2017-10-30 | 2017-12-04 | CNS LGG 2004 03 vinc weekly+ carbo | Y | N | 210019691 | CARBOPLATIN + VINCRISTINE |
| 210038121 | 210036061 | 0.87 | 14.8 | Curative (C) | 2019-10-21 | 2019-10-21 | CHOP - 21 days | N | N | 210021334 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 210038122 | 210010255 | 1.72 | null | Palliative (P) | 2015-02-28 | 2015-07-30 | Cyclophosphamide + Vincristine | N | N | 210021606 | RIALTO TRIAL |
| 210038123 | 210010465 | 1.86 | 16.6 | Curative (C) | 2019-06-27 | 2019-06-30 | Cyclophosphamide+Fludara+TBI Allo | N | N | 210023222 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 210038124 | 210036861 | 1.08 | 85.2 | Curative (C) | 2016-10-02 | 2016-10-02 | AML 19 TRIAL | Y | null | 210025775 | SIOP |
| 210038125 | 210021031 | null | null | Curative (C) | 2018-08-20 | 2018-08-30 | FLUDARABINE | N | null | 210027027 | BR14 TRIAL |
| 210038126 | 210010805 | 1.72 | 68.8 | Curative (C) | 2016-10-26 | 2016-11-24 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE | N | N | 210027036 | HCX |
| 210038127 | 210010853 | 1.78 | 79.4 | Palliative (P) | 2015-09-05 | 2015-11-28 | Irinotecan + Temozolomide | N | N | 210027335 | SIOP |
| 210038128 | 210010868 | null | 101 | Curative (C) | 2019-12-02 | 2020-03-20 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 210027506 | TRASTUZUMAB |
| 210038129 | 210010875 | null | 69 | Palliative (P) | 2017-06-01 | 2017-09-23 | BEAM | N | N | 210027529 | BEVACIZUMAB + IRINOTECAN |
| 210038130 | 210011304 | null | 102.6 | Disease modification (D) | 2016-12-13 | 2016-12-18 | Bevacizumab + LOMUSTINE | N | N | 210029102 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210038131 | 210021593 | 1.02 | 10.5 | Curative (C) | 2017-08-03 | 2017-08-07 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | null | 210032019 | BEVACIZUMAB + IRINOTECAN |
| 210038132 | 210011928 | null | 74 | Curative (C) | 2014-07-02 | 2014-07-05 | IDARUBICIN | N | Y | 210032021 | ICE |
| 210038133 | 210012142 | 1.69 | null | Curative (C) | 2015-08-05 | 2015-08-07 | AML16 DA 3+8 | 1 | Y | 210033299 | CYCLET |
| 210038134 | 210012157 | null | 66.599 | Neo-adjuvant (N) | 2016-03-30 | 2016-06-30 | TAMIGA trial | 02 | N | 210033375 | ABVD |
| 210038135 | 210012303 | 1.64 | null | Curative (C) | 2017-10-26 | 2018-06-30 | BR14 TRIAL | Y | N | 210034037 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210038136 | 210012320 | null | 72.9 | Curative (C) | 2018-07-25 | 2018-07-25 | FLAG | Y | Y | 210034115 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210038137 | 210012343 | 1.61 | null | Curative (C) | 2019-07-05 | 2019-11-01 | Ofatumumab Loading | 02 | N | 210034234 | TAMIGA TRIAL |
| 210038138 | 210012397 | 0 | 108.5 | Adjuvant (A) | 2020-10-24 | 2020-10-31 | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | Y | N | 210034702 | CAPECITABINE |
| 210038139 | 210022068 | null | null | Palliative (P) | 2014-10-24 | 2014-10-24 | Nilotinib | N | N | 210037370 | CARBOPLATIN + LOMUSTINE + VINCRISTINE |
| 210038140 | 210012846 | 1.66 | 55.3 | Curative (C) | 2018-03-04 | 2018-10-07 | ECX | N | N | 210037617 | CISPLATIN |
| 210038141 | 210012986 | 1.58 | 91.2 | Disease modification (D) | 2016-12-07 | 2017-06-14 | Fludarabine IV | N | N | 210038312 | TRASTUZUMAB |
| 210038142 | 210013147 | 1.86 | 75.6 | Curative (C) | 2020-07-25 | 2020-07-26 | IVAC | N | null | 210039036 | CLARITY TRIAL |
| 210038143 | 210028053 | 1.63 | 70 | Curative (C) | null | 2018-07-21 | CARBOPLATIN + Procarbazine | Y | N | 210040628 | CVP |
| 210038144 | 210013494 | 1.73 | 66.599 | Disease modification (D) | 2015-12-03 | 2015-12-11 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | 210041021 | CYCLET |
| 210038145 | 210022532 | 1.6 | 41.2 | Curative (C) | 2019-05-12 | 2019-05-30 | Cyclophosphamide High Dose | 02 | Y | 210042069 | EPIRUBICIN |
| 210038146 | 210013789 | 1.68 | null | Curative (C) | 2019-07-24 | 2019-07-24 | DA 3 + 10 | Y | N | 210028705 | CISPLATIN + GEMCITABINE |
| 210038147 | 210014053 | 1.67 | 82.3 | Curative (C) | 2020-02-18 | 2020-04-28 | CLARITY Trial | N | N | 210041781 | CYTARABINE INTRATHECAL |
| 210038148 | 210004305 | 1.65 | 43.8 | Palliative (P) | 2015-09-20 | 2015-09-20 | TEMOZOLOMIDE | N | N | 210000122 | TEMOZOLOMIDE |
| 210038151 | 210004761 | null | null | Curative (C) | 2018-02-27 | 2018-05-22 | Temozolomide 200mg/m2 | N | null | 210002776 | TEMOZOLOMIDE |
| 210038152 | 210017530 | 1.61 | null | Adjuvant (A) | 2018-04-14 | 2018-05-14 | Temozolomide 200mg/m2 | N | N | 210004002 | TEMOZOLOMIDE |
| 210038153 | 210005023 | null | 88 | Curative (C) | 2016-12-11 | 2017-02-25 | Temozolomide 200mg/m2 | N | Y | 210004223 | TEMOZOLOMIDE |
| 210038154 | 210005062 | 1.44 | 15.3 | Curative (C) | 2017-10-22 | 2018-08-13 | ALL UKALL2011 Maintenance A1 | Y | N | 210004402 | UKALL2011 |
| 210038155 | 210017578 | null | 32.6 | Curative (C) | 2014-07-16 | 2015-01-28 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210004493 | UKALL2011 |
| 210038156 | 210017581 | 1.76 | 105 | Curative (C) | 2016-04-13 | 2017-03-30 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210004496 | UKALL2011 |
| 210038157 | 210029670 | null | 15.9 | Curative (C) | 2017-04-22 | 2018-01-14 | ALL UKALL2011 Maintenance A1 | 1 | N | 210004715 | UKALL2011 |
| 210038158 | 210032632 | null | 21.2 | Curative (C) | 2017-05-23 | 2017-06-06 | ALL UKALL2011 Maintenance A3 | Y | null | 210004847 | UKALL2011 |
| 210038159 | 210005177 | 0.71 | 41.6 | Curative (C) | 2018-05-18 | 2018-08-28 | ALL UKALL2011 Std Int Maint A | Y | null | 210005122 | UKALL2011 |
| 210038160 | 210017633 | 1.76 | 56.5 | Curative (C) | 2014-02-13 | 2014-09-23 | ALL UKALL2011 Del Int C Recon PAsp | N | N | 210005131 | UKALL2011 |
| 210038161 | 210017640 | 0 | 14.7 | Curative (C) | 2014-09-22 | 2015-01-31 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | N | 210005198 | UKALL2011 |
| 210038162 | 210005231 | null | 11.9 | Curative (C) | 2015-11-30 | 2016-07-23 | ALL UKALL2011 Maintenance C1 | Y | N | 210005288 | UKALL2011 |
| 210038163 | 210005236 | null | 14.8 | Curative (C) | 2015-01-11 | 2015-06-06 | ALL UKALL2011 Cap Int Maint C PAsp | Y | N | 210005293 | UKALL2011 |
| 210038164 | 210017661 | 0 | 23.1 | null | 2018-08-06 | 2018-08-20 | ALL UKALL2011 Del Intens B Pt2 | null | N | 210005410 | UKALL2011 |